LY2886721

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for LY2886721, covering 2018-05-18 to 2019-09-16. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of LY2886721 Single Doses in Healthy Subjects [Phase 1]